Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A ROTH

Showing results (411-420 of 508) with videos related to

Pageof 51
Sort By:
Oncogene|March 4, 2000
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cellsJ Shao, T Fujiwara, Y Kadowaki, et al.
American Journal of Clinical Oncology|March 10, 2001
Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junctionI I Schnirer, R Komaki, J C Yao, et al.
Carcinogenesis|September 1, 1995
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotypeX Jin, X Wu, J A Roth, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Human Cell|March 1, 1996
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer]T Fujiwara, S Kagawa, N Ogawa, et al.
American Journal of Veterinary Research|August 1, 1980
Thymic abnormalities and growth hormone deficiency in dogsJ A Roth, L G Lomax, N Altszuler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancersM Hamada, T Fujiwara, A Hizuta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junctionJ A Ajani, J A Roth, M B Ryan, et al.
Neurotoxicology|January 1, 1989
Effect of chronic exposure to hexachlorophene on rat brain cell specific marker enzymesM P Kung, P A Nickerson, F M Sansone, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 1, 1997
Ultrarapid train stimulation versus conventional programmed electrical stimulation for induction of ventricular arrhythmias in patients with coronary artery diseaseJ D Fisher, M C Cua, S B Platt, et al.
Pageof 51

Showing results (411-420 of 508) with videos related to

Sort By:
Pageof 51
Oncogene|March 4, 2000
Overexpression of the wild-type p53 gene inhibits NF-kappaB activity and synergizes with aspirin to induce apoptosis in human colon cancer cellsJ Shao, T Fujiwara, Y Kadowaki, et al.
American Journal of Clinical Oncology|March 10, 2001
Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junctionI I Schnirer, R Komaki, J C Yao, et al.
Carcinogenesis|September 1, 1995
Higher lung cancer risk for younger African-Americans with the Pro/Pro p53 genotypeX Jin, X Wu, J A Roth, et al.
The Journal of Experimental Medicine|October 1, 1983
Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cellsE A Grimm, R J Robb, J A Roth, et al.
Human Cell|March 1, 1996
[Recombinant virus-mediated transfer of the wild-type p53 gene is a potent therapeutic strategy for human cancer]T Fujiwara, S Kagawa, N Ogawa, et al.
American Journal of Veterinary Research|August 1, 1980
Thymic abnormalities and growth hormone deficiency in dogsJ A Roth, L G Lomax, N Altszuler, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1996
The p53 gene is a potent determinant of chemosensitivity and radiosensitivity in gastric and colorectal cancersM Hamada, T Fujiwara, A Hizuta, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1993
Intensive preoperative chemotherapy with colony-stimulating factor for resectable adenocarcinoma of the esophagus or gastroesophageal junctionJ A Ajani, J A Roth, M B Ryan, et al.
Neurotoxicology|January 1, 1989
Effect of chronic exposure to hexachlorophene on rat brain cell specific marker enzymesM P Kung, P A Nickerson, F M Sansone, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|February 1, 1997
Ultrarapid train stimulation versus conventional programmed electrical stimulation for induction of ventricular arrhythmias in patients with coronary artery diseaseJ D Fisher, M C Cua, S B Platt, et al.
Pageof 51